Merck & Co , Inc Mrk Stock Cost, Quote & News
Third-quarter final results out Tuesday morning showed the value of Keytruda, the company’s immunotherapy drug. Merck booked sales of $12.four billion, great for 15% development from a year earlier and effectively ahead of analyst...
